马应龙 (600993)

Mayinglong Pharmaceutical Group Co., Ltd.

ASH

Tags

QFII Heavy PositionsSSE 380 IndexTraditional Chinese MedicinePension FundsInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareGene ConceptPrivate HospitalsHigh-Performing StocksMargin Trading and Securities Lending医药生物中药Ⅱ

K-Line Chart

No K-line data available

Company NameMayinglong Pharmaceutical Group Co., Ltd.
Listing Date2004-05-17
Issue Price16.11RMB
Registered Capital43105.389110k RMB
Legal RepresentativeChen Ping
Registered AddressNo. 100, Zhoujiawan, Nanhu, Wuchang District, Wuhan City, Hubei Province, China
IndustryTraditional Chinese Medicine II
Main BusinessManufacturing of Chinese and Western medicines.
Company ProfileFounded in 1582 AD, after over 400 years of development, it has evolved into a specialized listed pharmaceutical company. It is one of the first batch of "China Time-honored Brands" recognized by the Ministry of Commerce. The company was listed on the Shanghai Stock Exchange in 2004 and is recognized as a National High-Tech Enterprise, possessing a National Enterprise Technology Center. In 2011, the Mayinglong Babao ancient formula and eye ointment production techniques were recognized by the State Council as National Intangible Cultural Heritage. Guided by the development philosophy of "Unified Target Customers, Diversified Service Functions", the company has formed a complete industrial chain encompassing drug operation, diagnosis and treatment technologies, and medical services, aiming to become a provider of anorectal health solutions and build a commercial ecosystem.

Stock Details

1. Key Indicators

  • Total Shares(W): 43105.39
  • Circulating A-Shares(W): 43030.70
  • Earnings Per Share(RMB): 1.1600
  • Net Assets Per Share(RMB): 9.9743
  • Operating Revenue(W RMB): 283728.19
  • Total Profit(W RMB): 60810.59
  • **Net Profit Attributable to Parent(W RMB) **: 50101.07
  • Net Profit Growth Rate(%): 9.51
  • Weighted Return on Equity(%): 11.8500
  • Operating Cash Flow Per Share(RMB): 1.0440
  • Undistributed Profit Per Share(RMB): 8.2284
  • Capital Reserve Per Share(RMB): 0.0544

2. Main Business

The main business covers:

  • Chinese and Western Medicine Manufacturing

3. Company Basic Information

  • Company Name: Mayinglong Pharmaceutical Group Co., Ltd.
  • Listing Date: 2004-05-17
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 100, Zhoujiawan, Nanhu, Wuchang District, Wuhan City, Hubei Province
  • Website: https://www.mayinglong.cn/
  • Company Profile: The company was established with the approval of the former Wuhan Economic System Reform Commission (Document No. Wutigai [1993] 189). It was founded through a定向募集(directed placement) by the Wuhan Third Pharmaceutical Factory, Hubei Provincial Traditional Chinese Medicine Materials Company, and Wuhan Fourth Pharmaceutical Factory, based on the overall restructuring of the Wuhan Third Pharmaceutical Factory. The company was registered with the Wuhan Administration for Industry and Commerce on May 9, 1994.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China Baoan Group Co., Ltd. General Legal Person 12616.33 29.32
2 Wuhan State-owned Capital Investment and Operation Group Co., Ltd. General Legal Person 2244.97 5.22
3 China Merchants Balanced Preferred Hybrid Securities Investment Fund Class A Fund 952.60 2.21
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 820.61 1.91
5 Fullgoal Tianhui Selected Growth Hybrid Securities Investment Fund (LOF) Class A Fund 800.00 1.86
6 Basic Pension Insurance Fund Portfolio 807 Social Security Fund 752.78 1.75
7 JY Schroder New Vitality Flexible Allocation Hybrid Securities Investment Fund Class A Fund 666.22 1.55
8 Hong Kong Monetary Authority - Own Funds QFII 664.98 1.55
9 UBS Asset Management (Singapore) Ltd - UBS (Lux) Equity SICAV QFII 564.69 1.31
10 China Merchants Quality Discovery Hybrid Securities Investment Fund Class A Fund 526.91 1.22

5. Concept Sectors

  • Private Hospitals
  • Gene Concept
  • Margin Trading & Securities Lending
  • Blue Chip Stocks
  • QFII Heavy Holdings
  • Pension Funds
  • Fund Increased Holdings
  • SSE 380 Index

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information